Showing results (61-70 of 332) with videos related to

Sort By:
Pageof 34
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential SolutionsSarah Wordsworth, Brett Doble, Katherine Payne, et al.
Transfusion|January 31, 2018
Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health ServiceElizabeth A Stokes, Sarah Wordsworth, Julie Staves, et al.
Health and Quality of Life Outcomes|September 22, 2018
Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation studyBrett Doble, Maria Pufulete, Jessica M Harris, et al.
European Journal of Human Genetics : EJHG|June 13, 2019
Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular diseaseJames Buchanan, Edward Blair, Kate L Thomson, et al.
Obesity Surgery|October 29, 2018
Multi-Centre Micro-Costing of Roux-En-Y Gastric Bypass, Sleeve Gastrectomy and Adjustable Gastric Banding Procedures for the Treatment of Severe, Complex ObesityBrett Doble, Richard Welbourn, Nicholas Carter, et al.
European Heart Journal|March 20, 2010
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness modelSarah Wordsworth, José Leal, Edward Blair, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 30, 2011
Financial incentives and the health workforceAnthony Scott, Luke B Connelly
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2021
Development and implementation of an electronic medical record module to track genetic testing resultsAnthony Scott, Donna M Martin
The Medical Journal of Australia|January 20, 2012
Designing payments for GPs to improve the quality of diabetes careAnthony Scott, Mark F Harris
Pharmacoeconomics|August 2, 2017
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness AnalysisJames Buchanan, Sarah Wordsworth, Ruth Clifford, et al.
Pageof 34